Survival and Proliferation Factors of Normal and Malignant Plasma Cells
Tóm tắt
Since the first identification of interleukin (IL)-6 as a myeloma cell growth factor by Dr. Kawano’s and Dr. Klein’s groups 14 years ago, numerous studies have emphasized its major roles in the emergence of malignant plasma cells in vivo and in the generation of normal plasma cells. Four transcription factors control B-cell differentiation into plasma cells. The B-cell transcription factor pax-5 is mainly responsible for a B-cell phenotype, andbcl-6 represses the plasma cell transcription factor blimp-1 and plasma cell differentiation.bcl-6 expression is triggered by CD40 and IL-4 activation. A lack of CD40 and IL-4 activation yields a down-regulation ofbcl-6 expression, and IL-6 stimulation yields an up-regulation of blimp-1, mainly through STAT3 activation. Blimp-1 further down-regulatesbcl-6 andpax-5 expression and makes plasma cell differentiation possible. IL-6 as well as IL-10 up-regulate XBP-1. XBP-1 is another transcription factor that is involved in plasma cell differentiation and whose gene expression is shut down by pax-5.The plasma cell transcription factors blimp-1 and XBP-1 are up-regulated, and the B-cell transcription factors bcl-6 and pax-5 are down-regulated, in malignant cells compared to B-cells. Apart from the recent identification of these 4 transcription factors, the factors involved in normal plasma cell generation are mostly unknown. Regarding malignant plasma cells, 3 categories of growth factors have been identified: (1) the IL-6 family cytokines, IL-10, and interferon α that activate the Janus kinase—signal transducer and activator of transcription (JAK/STAT) and mitogen-activated protein (MAP) kinase pathways; (2) growth factors activating the phosphatidylinositol (PI)-3 kinase/AKT and MAP kinase pathways, unlike the JAK/STAT pathway (insulin-like growth factor 1, hepatocyte growth factor, and members of the epidermal growth factor family able to bind syndecan-1 proteoglycan); and (3) B-cell—activating factor (BAFF) or proliferationinducing ligand (APRIL) that activate the nuclear factor κB and PI-3 kinase/AKT pathways.BAFF and APRIL bind to BAFF receptor and TACI and are major B-cell survival factors. Recent data indicate that these various growth factors may cooperate to provide optimum signaling because they are localized together and with cytoplasmic transduction elements in caveolinlinked membrane caveolae. The identification of these myeloma cell growth factors and of the associated transduction pathways should provide novel therapeutic targets in multiple myeloma.
Tài liệu tham khảo
citation_journal_title=Blood.; citation_title=Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells; citation_author=G Jego, N Robillard, D Puthier; citation_volume=94; citation_publication_date=1999; citation_pages=701-712; citation_id=CR1
citation_journal_title=Blood.; citation_title=Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts; citation_author=K Tarte, J Vos, T Thykjaer; citation_volume=100; citation_publication_date=2002; citation_pages=1113-1122; citation_id=CR2
citation_journal_title=Annu Rev Immunol.; citation_title=Regulatory mechanisms that determine the development and function of plasma cells; citation_author=KL Calame, KI Lin, C Tunyaplin; citation_volume=21; citation_publication_date=2003; citation_pages=205-230; citation_doi=10.1146/annurev.immunol.21.120601.141138; citation_id=CR3
citation_journal_title=Eur J Immunol.; citation_title=Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10; citation_author=J Jung, J Choe, L Li, YS Choi; citation_volume=30; citation_publication_date=2000; citation_pages=2437-2443; citation_doi=10.1002/1521-4141(2000)30:8<2437::AID-IMMU2437>3.0.CO;2-M; citation_id=CR4
citation_journal_title=Blood.; citation_title=Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction; citation_author=K Agematsu, H Nagumo, Y Oguchi; citation_volume=91; citation_publication_date=1998; citation_pages=173-180; citation_id=CR5
citation_journal_title=Science.; citation_title=Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor; citation_author=K Yamasaki, T Taga, Y Hirata; citation_volume=241; citation_publication_date=1988; citation_pages=825-828; citation_doi=10.1126/science.3136546; citation_id=CR6
citation_journal_title=Proc Natl Acad Sci U S A.; citation_title=IgG1 plasmacytosis in interleukin 6 transgenic mice; citation_author=S Suematsu, T Matsuda, K Aozasa; citation_volume=86; citation_publication_date=1989; citation_pages=7547-7551; citation_doi=10.1073/pnas.86.19.7547; citation_id=CR7
citation_journal_title=Nature.; citation_title=Impaired immune and acutephase responses in interleukin-6-deficient mice; citation_author=M Kopf, H Baumann, G Freer; citation_volume=368; citation_publication_date=1994; citation_pages=339-342; citation_doi=10.1038/368339a0; citation_id=CR8
citation_journal_title=Int J Oncol.; citation_title=Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells; citation_author=XY Wen, AK Stewart, RR Sooknanan; citation_volume=15; citation_publication_date=1999; citation_pages=173-178; citation_id=CR9
citation_journal_title=Nature.; citation_title=Plasma cell differentiation requires the transcription factor XBP-1; citation_author=AM Reimold, NN Iwakoshi, J Manis; citation_volume=412; citation_publication_date=2001; citation_pages=300-307; citation_doi=10.1038/35085509; citation_id=CR10
citation_journal_title=Int Rev Immunol.; citation_title=Interleukin 6 and its receptor: ten years later; citation_author=T Hirano; citation_volume=16; citation_publication_date=1998; citation_pages=249-284; citation_doi=10.3109/08830189809042997; citation_id=CR11
citation_journal_title=Nature.; citation_title=Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma; citation_author=M Kawano, T Hirano, T Matsuda; citation_volume=332; citation_publication_date=1988; citation_pages=83-85; citation_doi=10.1038/332083a0; citation_id=CR12
citation_journal_title=Blood.; citation_title=Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6; citation_author=B Klein, XG Zhang, M Jourdan; citation_volume=73; citation_publication_date=1989; citation_pages=517-526; citation_id=CR13
citation_journal_title=Cancer.; citation_title=Interleukin-6 dependence of advanced malignant plasma cell dyscrasias; citation_author=XG Zhang, R Bataille, J Widjenes, B Klein; citation_volume=69; citation_publication_date=1992; citation_pages=1373-1376; citation_doi=10.1002/1097-0142(19920315)69:6<1373::AID-CNCR2820690612>3.0.CO;2-1; citation_id=CR14
citation_journal_title=Blood.; citation_title=Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia; citation_author=B Klein, J Wijdenes, XG Zhang; citation_volume=78; citation_publication_date=1991; citation_pages=1198-1204; citation_id=CR15
citation_journal_title=Blood.; citation_title=Biologic effects of antiinterleukin-6 (IL-6) murine monoclonal antibody in advanced multiple myeloma; citation_author=R Bataille, B Barlogie, ZY Lu; citation_volume=86; citation_publication_date=1995; citation_pages=685-691; citation_id=CR16
citation_journal_title=Blood.; citation_title=Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments; citation_author=ZY Lu, H Brailly, J Wijdenes, R Bataille, JF Rossi, B Klein; citation_volume=86; citation_publication_date=1995; citation_pages=3123-3131; citation_id=CR17
citation_journal_title=J Clin Invest.; citation_title=Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias; citation_author=R Bataille, M Jourdan, XG Zhang, B Klein; citation_volume=84; citation_publication_date=1989; citation_pages=2008-2011; citation_doi=10.1172/JCI114392; citation_id=CR18
citation_journal_title=Eur J Immunol.; citation_title=Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy; citation_author=JP Gaillard, R Bataille, H Brailly; citation_volume=23; citation_publication_date=1993; citation_pages=820-824; citation_doi=10.1002/eji.1830230408; citation_id=CR19
citation_journal_title=Eur J Immunol.; citation_title=In vivo interleukin-6 gene expression in the tumoral environment in multiple myeloma; citation_author=M Portier, G Rajzbaum, XG Zhang; citation_volume=21; citation_publication_date=1991; citation_pages=1759-1762; citation_doi=10.1002/eji.1830210727; citation_id=CR20
citation_journal_title=Br J Haematol.; citation_title=Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production; citation_author=V Costes, M Portier, ZY Lu, JF Rossi, R Bataille, B Klein; citation_volume=103; citation_publication_date=1998; citation_pages=1152-1160; citation_doi=10.1046/j.1365-2141.1998.01101.x; citation_id=CR21
citation_journal_title=Proc Natl Acad Sci U S A.; citation_title=Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2; citation_author=RM Hinson, JA Williams, E Shacter; citation_volume=93; citation_publication_date=1996; citation_pages=4885-4890; citation_doi=10.1073/pnas.93.10.4885; citation_id=CR22
citation_journal_title=Blood.; citation_title=Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion; citation_author=H Uchiyama, BA Barut, AF Mohrbacher, D Chauhan, KC Anderson; citation_volume=82; citation_publication_date=1993; citation_pages=3712-3720; citation_id=CR23
citation_journal_title=Blood.; citation_title=Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures; citation_author=HM Lokhorst, T Lamme, M Smet; citation_volume=84; citation_publication_date=1994; citation_pages=2269-2277; citation_id=CR24
citation_journal_title=Blood.; citation_title=Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma; citation_author=XG Zhang, JP Gaillard, N Robillard; citation_volume=83; citation_publication_date=1994; citation_pages=3654-3663; citation_id=CR25
citation_journal_title=Proc Natl Acad Sci U S A.; citation_title=IgG1 plasmacytosis in interleukin-6 transgenic mice; citation_author=S Suematsu, T Matsuda, K Aozasa; citation_volume=86; citation_publication_date=1989; citation_pages=7547-7551; citation_doi=10.1073/pnas.86.19.7547; citation_id=CR26
citation_journal_title=Proc Natl Acad Sci U S A.; citation_title=Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice; citation_author=S Suematsu, T Matsusaka, T Matsuda; citation_volume=89; citation_publication_date=1992; citation_pages=232-235; citation_doi=10.1073/pnas.89.1.232; citation_id=CR27
citation_journal_title=Am J Pathol.; citation_title=Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice; citation_author=G Lattanzio, C Libert, M Aquilina; citation_volume=151; citation_publication_date=1997; citation_pages=689-696; citation_id=CR28
citation_journal_title=J Exp Med.; citation_title=Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130; citation_author=XG Zhang, ZJ Gu, ZY Lu; citation_volume=179; citation_publication_date=1994; citation_pages=1337-1342; citation_doi=10.1084/jem.179.4.1337; citation_id=CR29
citation_title=Growth factors in the pathogenesis of multiple myeloma; citation_inbook_title=Multiple Myeloma; citation_publication_date=1996; citation_pages=73-82; citation_id=CR30; citation_author=B Klein; citation_publisher=Edward Arnold Publishers
citation_journal_title=J Immunol.; citation_title=IFN-alpha induced autocrine production of IL-6 in myeloma cell lines; citation_author=M Jourdan, XG Zhang, M Portier, JM Boiron, R Bataille, B Klein; citation_volume=147; citation_publication_date=1991; citation_pages=4402-4407; citation_id=CR31
citation_journal_title=J Immunol.; citation_title=IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis; citation_author=M Ferlin-Bezombes, M Jourdan, J Liautard, J Brochier, JF Rossi, B Klein; citation_volume=161; citation_publication_date=1998; citation_pages=2692-2699; citation_id=CR32
citation_journal_title=J Biol Chem.; citation_title=Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression; citation_author=T Arora, DF Jelinek; citation_volume=273; citation_publication_date=1998; citation_pages=11799-11805; citation_doi=10.1074/jbc.273.19.11799; citation_id=CR33
citation_journal_title=Blood.; citation_title=Interleukin-10 is a growth factor for human myeloma cells; citation_author=ZY Lu, XG Zhang, J Wijdenes; citation_volume=85; citation_publication_date=1995; citation_pages=2521-2527; citation_id=CR34
citation_journal_title=Blood.; citation_title=Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop; citation_author=ZJ Gu, V Costes, ZY Lu; citation_volume=88; citation_publication_date=1996; citation_pages=3972-3986; citation_id=CR35
citation_journal_title=Br J Haematol.; citation_title=JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogenactivated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells; citation_author=J Vos, M Jourdan, K Tarte, C Jasmin, B Klein; citation_volume=109; citation_publication_date=2000; citation_pages=823-828; citation_doi=10.1046/j.1365-2141.2000.02127.x; citation_id=CR36
citation_journal_title=Cell Death Differ.; citation_title=Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1; citation_author=M Jourdan, JD os, N Mechti, B Klein; citation_volume=7; citation_publication_date=2000; citation_pages=1244-1252; citation_doi=10.1038/sj.cdd.4400758; citation_id=CR37
citation_journal_title=Immunity.; citation_title=Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells; citation_author=R Catlett-Falcone, TH Landowski, MM Oshiro; citation_volume=10; citation_publication_date=1999; citation_pages=105-115; citation_doi=10.1016/S1074-7613(00)80011-4; citation_id=CR38
citation_journal_title=Br J Haematol.; citation_title=Mcl-1 and bcl-xL are co-regulated by IL-6 in human myeloma cells; citation_author=D Puthier, S Derenne, S Barille; citation_volume=107; citation_publication_date=1999; citation_pages=392-395; citation_doi=10.1046/j.1365-2141.1999.01705.x; citation_id=CR39
citation_journal_title=Blood.; citation_title=Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells; citation_author=S Derenne, B Monia, NM Dean; citation_volume=100; citation_publication_date=2002; citation_pages=194-199; citation_doi=10.1182/blood.V100.1.194; citation_id=CR40
citation_journal_title=Oncogene.; citation_title=A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells; citation_author=M Jourdan, JL Veyrune, JD Vos, N Redal, G Couderc, B Klein; citation_volume=22; citation_publication_date=2003; citation_pages=2950-2959; citation_doi=10.1038/sj.onc.1206423; citation_id=CR41
citation_journal_title=Cancer Res.; citation_title=The phosphatidylinositol 3-kinase/ AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses; citation_author=Y Tu, A Gardner, A Lichtenstein; citation_volume=60; citation_publication_date=2000; citation_pages=6763-6770; citation_id=CR42
citation_journal_title=Science.; citation_title=STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor; citation_author=LM Pfeffer, JE Mullersman, SR Pfeffer, A Murti, W Shi, CH Yang; citation_volume=276; citation_publication_date=1997; citation_pages=1418-1420; citation_doi=10.1126/science.276.5317.1418; citation_id=CR43
citation_journal_title=Oncogene.; citation_title=Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications; citation_author=CS Mitsiades, N Mitsiades, V Poulaki; citation_volume=21; citation_publication_date=2002; citation_pages=5673-5683; citation_doi=10.1038/sj.onc.1205664; citation_id=CR44
citation_journal_title=Blood.; citation_title=Insulinlike growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk; citation_author=YW Qiang, E Kopantzev, S Rudikoff; citation_volume=99; citation_publication_date=2002; citation_pages=4138-4146; citation_doi=10.1182/blood.V99.11.4138; citation_id=CR45
citation_journal_title=Oncogene.; citation_title=Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma; citation_author=F Pene, YE Claessens, O Muller; citation_volume=21; citation_publication_date=2002; citation_pages=6587-6597; citation_doi=10.1038/sj.onc.1205923; citation_id=CR46
citation_journal_title=Blood.; citation_title=Insulinlike growth factor I is a growth and survival factor in human multiple myeloma cell lines; citation_author=P Georgii-Hemming, HJ Wiklund, O Ljunggren, K Nilsson; citation_volume=88; citation_publication_date=1996; citation_pages=2250-2258; citation_id=CR47
citation_journal_title=J Immunol.; citation_title=A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth; citation_author=DF Jelinek, TE Witzig, BK Arendt; citation_volume=159; citation_publication_date=1997; citation_pages=487-496; citation_id=CR48
citation_journal_title=Br J Haematol.; citation_title=Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway; citation_author=M Ferlin, N Noraz, C Hertogh, J Brochier, N Taylor, B Klein; citation_volume=111; citation_publication_date=2000; citation_pages=626-634; citation_doi=10.1046/j.1365-2141.2000.02364.x; citation_id=CR49
citation_journal_title=Blood.; citation_title=Insulin-like growth factor I is a dual effector of multiple myeloma cell growth; citation_author=NL Ge, S Rudikoff; citation_volume=96; citation_publication_date=2000; citation_pages=2856-2861; citation_id=CR50
citation_journal_title=Oncogene.; citation_title=Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma; citation_author=T Hideshima, N Nakamura, D Chauhan, KC Anderson; citation_volume=20; citation_publication_date=2001; citation_pages=5991-6000; citation_doi=10.1038/sj.onc.1204833; citation_id=CR51
citation_journal_title=Oncogene.; citation_title=Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses; citation_author=JH Hsu, Y Shi, L Hu, M Fisher, TF Franke, A Lichtenstein; citation_volume=21; citation_publication_date=2002; citation_pages=1391-1400; citation_doi=10.1038/sj.onc.1205194; citation_id=CR52
citation_journal_title=Oncogene.; citation_title=Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo; citation_author=NL Ge, S Rudikoff; citation_volume=19; citation_publication_date=2000; citation_pages=4091-4095; citation_doi=10.1038/sj.onc.1203801; citation_id=CR53
citation_journal_title=Blood.; citation_title=Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor; citation_author=T Standal, M Borset, S Lenhoff; citation_volume=100; citation_publication_date=2002; citation_pages=3925-3929; citation_doi=10.1182/blood-2002-05-1406; citation_id=CR54
citation_journal_title=J Endocrinol.; citation_title=Specifying the cellular responses to IGF signals: roles of IGF-binding proteins; citation_author=C Duan; citation_volume=175; citation_publication_date=2002; citation_pages=41-54; citation_doi=10.1677/joe.0.1750041; citation_id=CR55
citation_journal_title=Blood.; citation_title=Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays; citation_author=J Vos, G Couderc, K Tarte; citation_volume=98; citation_publication_date=2001; citation_pages=771-780; citation_doi=10.1182/blood.V98.3.771; citation_id=CR56
citation_journal_title=Br J Haematol.; citation_title=A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1; citation_author=J Wijdenes, WC Vooijs, C Clement; citation_volume=94; citation_publication_date=1996; citation_pages=318-323; citation_doi=10.1046/j.1365-2141.1996.d01-1811.x; citation_id=CR57
citation_journal_title=Hum Pathol.; citation_title=The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens; citation_author=V Costes, V Magen, E Legouffe; citation_volume=30; citation_publication_date=1999; citation_pages=1405-1411; citation_doi=10.1016/S0046-8177(99)90160-0; citation_id=CR58
citation_journal_title=Faseb J.; citation_title=The syndecans, tuners of transmembrane signaling; citation_author=P Zimmermann, G David; citation_volume=13; citation_publication_date=1999; citation_pages=S91-S100; citation_doi=10.1096/fasebj.13.9001.s91; citation_id=CR59
citation_journal_title=Oncogene.; citation_title=Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells; citation_author=YD Wang, J Vos, M Jourdan; citation_volume=21; citation_publication_date=2002; citation_pages=2584-2592; citation_doi=10.1038/sj.onc.1205355; citation_id=CR60
citation_journal_title=Front Biosci.; citation_title=Structure and function of heparin-binding EGF-like growth factor (HB-EGF); citation_author=KM Davis-Fleischer, GE Besner; citation_volume=3; citation_publication_date=1998; citation_pages=d288-299; citation_doi=10.2741/A241; citation_id=CR61
citation_journal_title=Front Biosci.; citation_title=The role of EGFrelated peptides in tumor growth; citation_author=N Normanno, C Bianco, A Luca, DS Salomon; citation_volume=6; citation_publication_date=2001; citation_pages=D685-707; citation_doi=10.2741/A635; citation_id=CR62
citation_journal_title=Oncogene.; citation_title=The EGF receptor family as targets for cancer therapy; citation_author=J Mendelsohn, J Baselga; citation_volume=19; citation_publication_date=2000; citation_pages=6550-6565; citation_doi=10.1038/sj.onc.1204082; citation_id=CR63
citation_journal_title=Blood.; citation_title=Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma; citation_author=PW Derksen, RM Keehnen, LM Evers, MH Oers, M Spaargaren, ST Pals; citation_volume=99; citation_publication_date=2002; citation_pages=1405-1410; citation_doi=10.1182/blood.V99.4.1405; citation_id=CR64
citation_journal_title=Blood.; citation_title=Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group; citation_author=C Seidel, M Borset, I uresson, N Abildgaard, A Sundan, A Waage; citation_volume=91; citation_publication_date=1998; citation_pages=806-812; citation_id=CR65
citation_journal_title=Blood.; citation_title=Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease; citation_author=O Hjertner, ML Torgersen, C Seidel; citation_volume=94; citation_publication_date=1999; citation_pages=3883-3888; citation_id=CR66
citation_journal_title=Cancer Res.; citation_title=High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies; citation_author=H Avet-Loiseau, JY Li, T Facon; citation_volume=58; citation_publication_date=1998; citation_pages=5640-5645; citation_id=CR67
citation_journal_title=Br J Haematol.; citation_title=FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance; citation_author=T Rasmussen, HR Hudlebusch, LM Knudsen, HE Johnsen; citation_volume=117; citation_publication_date=2002; citation_pages=626-628; citation_doi=10.1046/j.1365-2141.2002.03429.x; citation_id=CR68
citation_journal_title=Nat Genet.; citation_title=Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3; citation_author=M Chesi, E Nardini, LA Brents; citation_volume=16; citation_publication_date=1997; citation_pages=260-264; citation_doi=10.1038/ng0797-260; citation_id=CR69
citation_journal_title=Jpn J Cancer Res.; citation_title=Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity; citation_author=N Sato, Y Hattori, D Wenlin; citation_volume=93; citation_publication_date=2002; citation_pages=459-466; citation_doi=10.1111/j.1349-7006.2002.tb01278.x; citation_id=CR70
citation_journal_title=Mol Biol Cell.; citation_title=Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation; citation_author=KC Hart, SC Robertson, DJ Donoghue; citation_volume=12; citation_publication_date=2001; citation_pages=931-942; citation_doi=10.1091/mbc.12.4.931; citation_id=CR71
citation_journal_title=Blood.; citation_title=Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma; citation_author=M Chesi, LA Brents, SA Ely; citation_volume=97; citation_publication_date=2001; citation_pages=729-736; citation_doi=10.1182/blood.V97.3.729; citation_id=CR72
citation_journal_title=Blood.; citation_title=Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance; citation_author=JB Pollett, S Trudel, D Stern, ZH Li, AK Stewart; citation_volume=100; citation_publication_date=2002; citation_pages=3819-3821; citation_doi=10.1182/blood-2002-02-0608; citation_id=CR73
citation_journal_title=Curr Opin Immunol.; citation_title=TNF ligands and receptors in autoimmunity: an update; citation_author=F Mackay, SL Kalled; citation_volume=14; citation_publication_date=2002; citation_pages=783-790; citation_doi=10.1016/S0952-7915(02)00407-7; citation_id=CR74
citation_journal_title=Nat Rev Immunol.; citation_title=BAFF: a fundamental survival factor for B cells; citation_author=F Mackay, JL Browning; citation_volume=2; citation_publication_date=2002; citation_pages=465-475; citation_doi=10.1038/nri844; citation_id=CR75
citation_journal_title=Blood.; citation_title=A molecular compendium of genes expressed in multiple myeloma; citation_author=JO Claudio, E Masih-Khan, H Tang; citation_volume=100; citation_publication_date=2002; citation_pages=2175-2186; citation_doi=10.1182/blood-2002-01-0008; citation_id=CR76
Tarte K, Moreaux J, Legouffe E, Rossi JF, Klein B. BAFF is a survival factor for multiple myeloma cells.Blood. 2002
citation_journal_title=J Immunol.; citation_title=Transactivation of gp130 in myeloma cells; citation_author=JD French, DK Walters, DF Jelinek; citation_volume=170; citation_publication_date=2003; citation_pages=3717-3723; citation_doi=10.4049/jimmunol.170.7.3717; citation_id=CR78
citation_journal_title=Oncogene.; citation_title=Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex; citation_author=DK Walters, JD French, BK Arendt, DF Jelinek; citation_volume=22; citation_publication_date=2003; citation_pages=3598-3607; citation_doi=10.1038/sj.onc.1206512; citation_id=CR79
citation_journal_title=J Biol Chem.; citation_title=Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells; citation_author=K Podar, YT Tai, CE Cole; citation_volume=278; citation_publication_date=2003; citation_pages=5794-5801; citation_doi=10.1074/jbc.M208636200; citation_id=CR80
citation_journal_title=J Biol Chem.; citation_title=The major CD9 and CD81 molecular partner. Identification and characterization of the complexes; citation_author=S Charrin, F Naour, M Oualid; citation_volume=276; citation_publication_date=2001; citation_pages=14329-14337; citation_doi=10.1074/jbc.M011297200; citation_id=CR81